Though lung cancer is still the deadliest cancer, causing 1 in 5 cancer deaths, most eligible for annual lung cancer ...
VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q Cancer Test differentiated between malignant and ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q® Cancer Test differentiated ...